Skye Bioscience, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Cover
- Document and Entity Information
Financial Statements
Notes to Financial Statements
Accounting Policies
- Nature of Operations, Business Activities and Summary of Significant Accounting Policies (Policies)
Notes Tables
Notes Details

Provision for Conversion of Preferred Stock (Detail Textuals)

v3.8.0.1

Provision for Conversion of Preferred Stock (Detail Textuals) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Nov. 01, 2017	Dec. 31, 2015	Aug. 20, 2015
Series B Preferred Stock Conversion Liability
Conversion of Stock [Line Items]
Fair value of embedded derivative	$ 6,715	$ 118,821		$ 75,488
Series B Preferred Stock Conversion Liability \| Nonoperating Income (Expense)
Conversion of Stock [Line Items]
Change in fair market value of embedded derivative	102,848	$ (48,564)
Series F Preferred Stock Put Option Liability
Conversion of Stock [Line Items]
Fair value of embedded derivative			$ 103,364
Series F Preferred Stock Put Option Liability \| Nonoperating Income (Expense)
Conversion of Stock [Line Items]
Change in fair market value of embedded derivative	$ 103,364
Series B Preferred Stock
Conversion of Stock [Line Items]
Shares issued, price per share (in dollars per share)		$ 0.25			$ 0.80
Series F Preferred Stock
Conversion of Stock [Line Items]
Shares issued, price per share (in dollars per share)	$ 0.10

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_ConversionOfStockLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Fair value as of the balance sheet date of the embedded derivative or group of embedded derivatives classified as a liability.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4B
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=84234895&loc=SL5624163-113959

+ Details

Name:	us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Net Increase or Decrease in the fair value of the embedded derivative or group of embedded derivatives included in earnings in the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4C
-URI http://asc.fasb.org/extlink&oid=84234895&loc=SL5624171-113959

+ Details

Name:	us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Per share or per unit amount of equity securities issued.

+ References

No definition available.

+ Details

Name:	us-gaap_SharesIssuedPricePerShare
Namespace Prefix:	us-gaap_
Data Type:	num:perShareItemType
Balance Type:	na
Period Type:	instant

- Details

Name:	us-gaap_DerivativeInstrumentRiskAxis=nmus_SeriesBPreferredStockConversionLiabilityMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_IncomeStatementLocationAxis=us-gaap_NonoperatingIncomeExpenseMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_DerivativeInstrumentRiskAxis=nmus_SeriesFPreferredStockPutOptionLiabilityMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementClassOfStockAxis=us-gaap_SeriesFPreferredStockMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: